Cancer treatment is rapidly evolving with the introduction of targeted therapies that offer improved treatment outcomes. Rucaparib 200mg and Rucaparib 300mg tablets are among the most advanced therapies available for patients diagnosed with recurrent ovarian cancer and BRCA-mutated cancers.
Cordium Pharmaceuticals Pvt Ltd is a trusted global exporter and supplier of high-quality oncology medicines, delivering reliable pharmaceutical solutions to healthcare providers, distributors, hospitals, and importers across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What Are Rucaparib 200mg/300mg Tablets?
Rucaparib is a PARP inhibitor medicine prescribed for adults suffering from specific types of ovarian, fallopian tube, and primary peritoneal cancers.
This targeted therapy works by blocking DNA repair mechanisms inside cancer cells, making it difficult for them to survive and multiply.
Rucaparib is commonly used for:
- Advanced ovarian cancer treatment
- Recurrent ovarian cancer management
- BRCA-positive ovarian cancer
- Fallopian tube cancer treatment
- Primary peritoneal cancer treatment
- Maintenance therapy following platinum-based chemotherapy
How Rucaparib Supports Cancer Treatment
Unlike conventional chemotherapy, Rucaparib is a precision medicine that targets cancer cells while reducing damage to healthy tissues.
Treatment Benefits
✔ Supports personalized cancer treatment
✔ Helps slow disease progression
✔ Suitable for long-term maintenance therapy
✔ Oral tablet formulation for patient convenience
✔ Effective in BRCA gene-mutated cancers
✔ Widely adopted in modern oncology protocols
Available Strengths
Cordium Pharmaceuticals Pvt Ltd supplies:
Rucaparib 200mg Tablets
Suitable for dose adjustments as prescribed by oncologists.
Rucaparib 300mg Tablets
Used to achieve standard therapeutic dosing requirements.
Dosage should only be determined by a qualified healthcare professional.
Who May Benefit From Rucaparib Therapy?
Patients diagnosed with:
- Epithelial ovarian cancer
- Recurrent ovarian cancer
- BRCA-mutated cancers
- Platinum-sensitive ovarian cancer
- Fallopian tube cancer
- Primary peritoneal cancer
Doctors may perform genetic testing before initiating treatment.
Common Side Effects
Patients may experience:
- Nausea
- Fatigue
- Vomiting
- Loss of appetite
- Constipation
- Diarrhea
- Anemia
- Elevated liver enzymes
- Taste alterations
- Abdominal discomfort
Regular monitoring is recommended during treatment.
Why Global Buyers Choose Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is focused on providing dependable oncology medicine supply solutions for international healthcare markets.
Our Competitive Advantages
✅ International pharmaceutical exports
✅ Oncology medicine specialization
✅ Reliable product sourcing
✅ Documentation support for importers
✅ Bulk supply capabilities
✅ Competitive pricing
✅ Consistent supply chain management
✅ Dedicated customer assistance
Countries We Serve
We actively support pharmaceutical businesses and healthcare institutions in:
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Southeast Asia
🇵🇭 Philippines
🇻🇳 Vietnam
Central Asia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Middle East
🇦🇪 UAE
🇸🇦 Saudi Arabia
Europe & North America
🇬🇧 United Kingdom
🇺🇸 United States
Industries We Supply
Cordium Pharmaceuticals Pvt Ltd works with:
- Oncology hospitals
- Pharmaceutical distributors
- Government procurement agencies
- Cancer treatment centers
- Healthcare importers
- International wholesalers
- Specialty pharmacies
Frequently Asked Questions
Is Rucaparib a chemotherapy medicine?
No. Rucaparib is a targeted anti-cancer therapy belonging to the PARP inhibitor class.
Is Rucaparib available in tablet form?
Yes. It is available in 200mg and 300mg oral tablets.
Can Rucaparib be used worldwide?
Availability depends on local regulatory approvals and country-specific import regulations.
Is a doctor's prescription necessary?
Yes. Rucaparib is a prescription-only medicine and should be used under oncologist supervision.
About Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is dedicated to expanding global access to high-quality oncology medicines by supporting healthcare providers and pharmaceutical partners worldwide.
Global Markets Served: Kenya | Nigeria | Ghana | Philippines | Vietnam | UAE | Saudi Arabia | Uzbekistan | Kazakhstan | USA | UK | South Africa
Disclaimer: This information is intended for educational and business awareness purposes only. Product availability and regulatory approvals vary by country. Always consult a licensed healthcare professional before initiating any treatment.
